Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2018)
Amphastar Pharmaceuticals (AMPH) posted Change in Intangibles of $4.4 million for Q1 2018, up 340.0% on a QoQ basis from $1.0 million in Q3 2017, and up 340.0% year-over-year from $1000000.0 in Q1 2017.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2018) Analysis & Trends
Amphastar Pharmaceuticals has reported Change in Intangibles for 2 years, with the latest figure at $4.4 million in Q1 2018.
- On a quarterly basis, Change in Intangibles rose 340.0% year-over-year to $4.4 million in Q1 2018; TTM through Dec 2018 was $4.4 million, a 46.67% increase from a year earlier, with the FY2018 full-year figure at $4.4 million, up 120.0% from the prior year.
- Change in Intangibles was $4.4 million for Q1 2018 at Amphastar Pharmaceuticals, up from $1.0 million in the prior quarter.
- The five-year high for Change in Intangibles was $4.4 million in Q1 2018, with the low at $1.0 million in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 22.34 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -16.90 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 4.40 Mn |
| Sep 30, 2017 | 1.00 Mn |
| Jun 30, 2017 | 1.00 Mn |
| Mar 31, 2017 | 1.00 Mn |